Cargando…
The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics
BACKGROUND: Cancer susceptibility candidate 2 (CASC2) is characterized as a tumor suppressor, which was first identified to be downregulated in endometrial carcinoma. Accumulating evidence was provided to testify the function of CASC2 in malignant tumors. However, a systematic and quantitative asses...
Autores principales: | Yu, Lingling, Chen, Shengsong, Bao, Hui, Zhang, Weifang, Liao, Minqi, Liang, Qian, Cheng, Xiaoshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065597/ https://www.ncbi.nlm.nih.gov/pubmed/30100741 http://dx.doi.org/10.2147/OTT.S166132 |
Ejemplares similares
-
LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020) -
Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis
por: Cui, Zhigang, et al.
Publicado: (2018) -
Significance of LncRNA CASC8 genetic polymorphisms on the tuberculosis susceptibility in Chinese population
por: Liu, Guoye, et al.
Publicado: (2020) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
HSP22 suppresses diabetes-induced endothelial injury by inhibiting mitochondrial reactive oxygen species formation
por: Yu, Lingling, et al.
Publicado: (2019)